Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 1 2 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 36 Prostatic Neoplasms 27 Carcinoma, Non-Small-Cell Lung 14 Lymphoma 13 Rectal Neoplasms 11 Lung Neoplasms 11 Head and Neck Neoplasms 11 Recurrence 10 Neoplasms 10 Neoplasm Metastasis 9 Carcinoma, Hepatocellular 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Esophageal Squamous Cell Carcinoma 8 Esophageal Neoplasms 8 Uterine Cervical Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Central Nervous System Neoplasms 7 Brain Neoplasms 7 Multiple Myeloma 6 Hyperthermia 6 Carcinoma, Intraductal, Noninfiltrating 6 Lymphoma, Follicular 5 Hodgkin Disease 5 Glioblastoma 5 Dendritic Cell Sarcoma, Interdigitating 5 Congenital Abnormalities 5 Colorectal Neoplasms 5

Interventions

sugemalimab 1 spartalizumab 1 Vinorelbine 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Liquid Biopsy 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Docetaxel 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NSCLC × Radiotherapy × Clear all

NCT02869685 2024-02-23

RadImm02

Xinqiao Hospital of Chongqing

Phase NA Completed

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡